Globenewswire.com ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) — BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the United States, today announced the launch of BioReference DirectTM, a new digital health platform designed to give consumers direct access to high-quality laboratory testing. Leveraging 45 years of […]
Search Results for: NEW JERSEY
04
Nov
Nov
Collaboration with Natera™ BioReference® is excited to announce a new collaboration with Natera™, a global leader in cell-free DNA testing and women’s health diagnostics. Together, our organizations are combining expertise to expand access to gold standard reproductive genetic testing for patients across New York and New Jersey.
Labcorp.com BURLINGTON, N.C. and MIAMI, Sept. 15, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today the completion of Labcorp’s acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. This acquisition includes BioReference Health’s laboratory testing businesses focused on oncology […]
PR Newswire Transaction to extend Labcorp’s leadership in oncology and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 11, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference […]
PR Newswire Transaction to enhance Labcorp’s laboratory services network and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 28, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select […]
Press Release
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
28
Nov
Nov
Elmwood Park, NJ – November 28, 2023 – BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data (“RWD”) for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions […]
Press Release
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
07
Nov
Nov
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON, MA, ELMWOOD PARK, NJ, and Rolle, Switzerland, November 7, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that […]
Press Release
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
09
Feb
Feb
CINtec® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, NJ, February 9, 2023 – BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from […]
